Medicine
Laying the foundations for new cancer therapies
Research
ETH Zurich
The Italian scientist Nicola Aceto will receive the Swiss Science Prize Latsis 2021 worth CHF 100,000. Aceto is an associate professor at ETH Zurich and is being honoured for his groundbreaking discoveries in the field of cancer research.
Research with animals, a necessity for scientific progress
Research
EPFL
EPFL Summer Series: How science works. Despite the many advancements in developing innovative alternative methods, animal testing still plays an important role in biological and medical research, enabling scientists to make key new discoveries. At EPFL, performing high-quality research is a priority for scientists, as is taking proper care of the mice, rats and fish in the facilities.
Skin matters
Research
ETH Zurich
Skintegrity.CH is a transdisciplinary consortium for the largest organ of humans, the skin.
Faulty regulation of an architect gene can lead to rare bone disease
Research
EPFL
EPFL researchers found that, if expressed too early during embryonic development, one of the genes that orchestrate the formation of limbs can lead to a rare disorder of bone growth.
Rheon Medical is revolutionizing the surgical treatment of glaucoma
TechTransfer
EPFL
EPFL spin-off Rheon Medical has developed the world’s first adjustable glaucoma drainage system, which has already been used successfully in over 250 patients in Europe. The company, based at EPFL Innovation Park, closed a CHF 5.6 million Series C funding round in December 2020 and just received the U.S. FDA’s Breakthrough Device Designation for its technology.
Computer algorithms are currently revolutionising biology
Research
ETH Zurich
Artificial intelligence can help predict the three-dimensional structure of proteins. Beat Christen describes how such algorithms should soon help to develop tailored artificial proteins.
Page 2 of 21